Pilot-to-Paid Strategies

This isn’t just a self-assessment; it’s the first step in our GTM Diagnostic, a tool designed to provide clarity and actionable insights. Use it to demonstrate to customers and investors that you’re building a dependable, measurable process, not just a prototype.

Regulatory approval is a milestone worth celebrating. Pilots showing strong clinical value are significant achievements. Yet, for most MedTech founders, these victories lead to a sobering reality: stalled traction, investor pressure, and a pipeline of pilots that never convert.